Tissue optical clearing techniques have provided important tools for large-volume imaging. 15 Aqueous-based clearing methods are known for good fluorescence preservation and scalable size 16 maintenance, but are limited by either long incubation time, or insufficient clearing performance, 17 or requirements for specialized devices. Additionally, due to the use of high concentration organic 18 solvents or detergents, few clearing methods are compatible with lipophilic dyes while maintaining 19 high clearing performance. To address these issues, we developed a rapid, highly efficient aqueous 20 clearing method with robust compatibility, termed m-xylylenediamine (MXDA)-based Aqueous 21
Introduction 30 Three-dimensional (3D) imaging of tissue structures at high resolution plays an 31 indispensable role in life science. The development of diverse fluorescent labelling methods 32 and optical imaging techniques provides essential tools for 3D imaging of large-volume 33 tissues [1] [2] [3] [4] . However, the imaging depth is rather limited due to the opaqueness of tissue 5 . 34 Automated serial-sectioning and imaging techniques have been developed to address this 35 issue, allowing the acquisition of high-resolution images throughout the brain 6-9 . 36 As a distinct solution, tissue optical clearing technique has been proposed for 37 imaging deeper without cutting 10-13 . In the past decade, a variety of optical clearing methods 38 have been developed and are principally divided into solvent-based methods, such as 39 3DISCO 14, 15 , iDISCO 16 Ce3D 37 . These methods provide powerful tools for visualizing tissue structures and greatly 43 promote the development of life science. 44 Aqueous-based clearing methods are known for good fluorescence preservation and 45 scalable maintenance of tissue size 11 , but are also faced with poor clearing performance or 46 slow clearing speed. For example, SeeDB and Clear T performed well on embryos and 47 neonatal mouse tissues, while showed modest transparency in whole-mount adult tissues 38, 48 39 . CUBIC and CLARITY can achieve high tissue transparency but require long incubation 49 time for clarification (e.g., approximately 2-3 weeks for the whole brain). Moreover, due to 50 the usage of organic solvents or high concentration detergents, most clearing methods with 51 high clearing capability are incompatible with lipophilic dyes, such as DiI, which has been 52 Page 3 of 42 widely used to trace neuronal structures and vasculatures 26, [40] [41] [42] . These drawbacks have 53 limited their applications in researches. 54 In this work, we developed an aqueous clearing method based on m-xylylenediamine 55 (MXDA), termed MXDA-based Aqueous Clearing System (MACS). MACS achieved high 56 transparency of intact organs and rodent bodies in a fairly short time and showed ideal 57 compatibility with multiple probes, especially with lipophilic dyes. MACS is applicable for 58 imaging the neural structures of transgenic whole adult brains and immunostained mouse 59 embryos, as well as the neural projections throughout the whole brain labelled by viruses. 60 MACS also allows imaging of DiI-labelled vascular structures of various organs. MACS is 61 expected to promote comprehensive morphological and pathological studies of intact organs. 62 
Results

63
MACS enables rapid clearing of multiscale tissues 64 We successfully cleared the intact brain with a high level of transparency within only 65 2.5 d using our MACS protocol ( Fig. 1a ). Compared with other available clearing methods, 66 MACS renders brain samples highly transparent much faster ( Fig. 1a-c, Fig. S1a , c) and 67 nearly maintains the sample size after transient expansion ( Fig. 1d, Fig. S1b ). The computed 68 tomography (CT) reconstruction images revealed no significant changes of brain volume 69 before and after MACS clearing ( Fig. S2a, b) . The outlines and internal regions of the brain 70 slices overlapped well before and after MACS treatment ( Fig. S2c-h ). Furthermore, to 71 investigate the influence of MACS on the preservation of fine structures, we imaged a 72 typical pyramidal neuron and single microglia before and after clearing. The results showed 73 that MACS could maintain the cell morphology and fine structures well (Fig. S2i, j) . 74 MACS could also efficiently clarify other mouse tissues, including both soft internal 75 organs and hard bones (Fig. 1e ), and was also applicable for the adult mouse body (Fig. 1f ).
76
Page 4 of 42 Additionally, MACS was effective for intact adult rat organs ( Fig. S3a) . Notably, MACS 77 demonstrated superior ability in clearing mouse embryos and pups (Fig. S3b) . 78 We also found that MXDA solution could efficiently decolourize heme-rich tissues, 79 such as embryos (Fig. 1g ). The absorbance of the decolourizing medium indicated that 80 MXDA decolourized the samples in a manner similar to that of NaOH solution (release Fe) 81 but quite different from that of Quadrol solution (release heme) used in CUBIC 29 (Fig. 1h ). 82 Additionally, MXDA showed high pH stability over NaOH solution during clearing (Table   83   S1 ). The decolourizing capability of MXDA enables MACS to decolourize samples during 84 clarification ( Fig. S3c ). 86 Furthermore, we investigated the fluorescence preservation of MACS for both endogenous 87 fluorescent proteins and chemical fluorescent tracers. The results demonstrated that MACS 88 could preserve the endogenous EGFP, EYFP and tdTomato very well after clearing ( Fig. 2a , 89 b, Fig. S4a ). We also imaged MACS-cleared brain slices during long-term storage, and the 90 fluorescence intensity remained relatively high after one month ( Fig. 2c, Fig. S4b ). 91 DiI is a commonly used lipophilic fluorescent dye for neural tracing and vascular 92 labelling. Due to the high concentration of membrane-removing detergents or organic 93 solvents, CUBIC-L, PACT and uDISCO are not compatible with DiI labelling. By contrast, 94 MACS can preserve the fluorescence of DiI fairly well, similar to ScaleS and SeeDB2 (Fig. 95 2d). Indeed, MACS used neither detergents nor organic solvents, thus samples treated by 96 MACS maintained membrane integrity well, which was crucial for DiI signalling ( Fig. 2e ). 97 The superior compatibility enables visualization of neuronal projections in the DiI-labelled 98 hippocampus region in mouse brain tissue (Fig. 2f ). We also tested MACS with other types 99 of chemical tracers, including propidium iodide (PI) for nuclear staining, Tetramethylrhodamine-conjugated dextran for vessel labelling, virus-delivered proteins 101 (DsRed and mCherry) and fluorophore-conjugated antibodies in immunostaining 102 (AlexaFluor 594 (AF 594) and AlexaFluor 633 (AF 633)) ( Fig. 2f, Fig. S4c, d ). The results 103 showed that MACS maintained the fluorescence signals of all tested tracers well. 104 Additionally, previous studies demonstrated that CM-DiI could be used as an 105 alternative in CLARITY-based methods. CM-DiI is an aldehyde-fixably modified version 106 of DiI which adheres not only to the cellular membranes but also protein structures after 107 fixation, such that it would remain in the tissue after lipid extraction 43 . However, we found 108 that the signals from CM-DiI was only partial remained after treatment by CUBIC-L, PACT 109 and uDISCO, the signal loss was obvious as previously reported 44 . Due to the good 110 membrane integrity after MACS treatment, both the DiI and CM-DiI signals were well 111 maintained without any obvious loss ( Fig. S4e ). 113 Using the rapid MACS clearing protocol, we cleared transgenic whole mouse brains and 114 performed fluorescence imaging by light sheet fluorescence microscopy (LSFM). We 115 obtained the neurons in Thy1-GFP-M mouse brain at different depths and performed 3D 116 reconstruction ( Fig. 3a-d ). The fine neural structures were well observed in different brain 117 regions, including the midbrain, hippocampus, cerebellum, striatum, cortex, and cerebellar 118 nuclei ( Fig. 3e -j). We also cleared and imaged the Sst-IRES-Cre::Ai14 transgenic mouse 119 brain, and MACS allowed fine imaging of tdTomato fluorescence labelled neurons 120 throughout the whole brain at single-cell resolution ( Fig. S5a-e ). 121 Virus labelling is widely used to reveal neural circuits across the whole brain 45, 46 . 122 Here, we applied MACS protocol to visualize neuronal projections labelled by different 123 types of virus, including retrograde rabies virus (RV) and anterograde adeno-associated 124 Page 6 of 42 virus (AAV). We imaged the input and output of the nucleus reuniens (RE), which 125 reportedly receives afferent projections across the brain and is an important temporal 126 constraint in hippocampus-RE-mPFC circuits 47, 48 . We injected RV-DsRed and AAV-127 mCherry into the RE region for retrograde and anterograde tracing of the projections, 128 respectively ( Fig. S5f ). The 3D rendering of acquired images showed a diverse and widely 129 distributed set of afferents to RE (Fig. 3k ), which heavily projected from the dorsal/ventral 130 agranular insular cortex (AID/AIV), medial prefrontal cortex (mPFC), ventral CA1 of the 131 hippocampus, ectorhinal cortex (ECT), medial amygdaloid nucleus (MEA) ( Fig. 3l-q) , etc. 132 Moreover, the 3D rendering showed a relatively limited output from RE, which was mainly 133 directed to the hippocampal formation (e.g., CA1), ventral subiculum (S) and mPFC (Fig. 134 S5g-k), as previously reported 49 . 135 In addition to transgenic labelling and virus labelling, immunostaining is a powerful 136 method to label tissues. Due to the hyperhydration of MXDA used in MACS, we explored 137 whether MXDA pretreatment would enhance the permeability of antibodies in 138 immunostaining. The results revealed that MXDA pretreated samples could achieve deeper 139 staining than those without MXDA pretreatment . After MXDA pretreatment, 140 whole embryos were stained with neurofilament antibody and followed by MACS clearing 141 and imaging with LSFM ( Fig. S6d ). We obtained the 3D nerve distributions of embryos at 142 different ages ( Fig. 3r, Fig. S6e , j). The fine neural branches in the limbs, spinal cord, tail, 143 and whisker pad could be clearly visualized ( Fig. 3s -v, Fig. S6f -i). has been demonstrated experimentally to be more effective on specific mouse organs (e.g. 149 mouse spleen and kidney) than some common-used labelling methods ( Fig. S7 ). However, 150 few clearing methods could be applied to this labelling because of incompatibility. Here, 151 due to the superior compatibility with DiI and high clearing capability, we applied MACS 152 to acquire the vasculatures of DiI-labelled organs, including the whole mouse brain, spinal 153 cord and other internal organs. 154 After MACS clearing, the DiI-labelled vasculature of the whole brain could be 155 observed directly (Fig. 4a ). Combined with LSFM imaging, we visualized the brain 156 vasculature in 3D (Fig. 4b ). The detailed vascular structures in the cortex, middle of the 157 brain, cerebellum and hippocampus could be clearly identified ( Fig. 4c-f ). The sagittal view 158 showed the vascular distribution along the z-axis (Fig. 4g ). The spinal cord was also finely 159 imaged with both the central blood vessels and the surrounding capillaries distinguished 29, 31 . In this study, we found that MXDA 201 also had excellent decolourizing characteristic. The decolourization principle of MXDA is 202 different from that of Quadrol (releasing hemin) used in CUBIC but similar to that of NaOH 203 (releasing Fe) 29 . However, during immersion, the pH of NaOH solution showed an obvious 204 decrease, while MXDA showed high pH stability (Table S1 ). The decolourization effect of 205 MXDA enables MACS to directly extract residual chromophores in tissues, thus leading to 206 efficient clearing without any additional decolourization steps. Furthermore, MACS is 207 expected to be combined with solvent-based methods, which are often blood-sensitive, to 208 provide decolourization prior to clearing. thus demonstrates ideal compatibility with lipophilic dyes (Fig. 2d, e ), along with its high 224 clearing performance, MACS enables 3D visualization of DiI-labelled vascular structures 225 in various intact organs (Fig. 4) . Notably, the DiI labelling method could offer more detailed 226 vascular information than other commonly used methods in specific organs. This approach 227 is expected to facilitate the analysis of vasculature networks in specific disease models. 228 Recently, CM-DiI has been reported to be used as an alternative of DiI in CLARITY 229 method 43 . However, CM-DiI was experimentally only partial compatible with methods 230 using high concentration of detergents or organic solvents, such as CUBIC-L, PACT and 231 uDISCO. The signal loss was obvious, which was consistent with previously reported 44 . For 232 MACS, both the DiI and CM-DiI signals were well maintained without obvious loss. 233 Additionally, the CM-DiI dye is nearly 100 times more expensive than the common DiI dye 332 We measured the light transmittance of 2 mm thick mouse brain sections with a 333 commercially available spectrophotometer (Lambda 950, PerkinElmer, USA). Cleared 334 samples were placed on two glass slides covered with black tape, and a customized 3 mm× 335 3 mm slit was opened to obtain the collimated transmitted beam. We measured transmittance 336 spectra from 400 nm to 800 nm. 338 To measure the volume of the whole mouse brain, a customized microcomputed 339 Tomography (micro-CT) was used 56 . The whole mouse brains were imaged by micro-CT in different mice with the following coordinates: bregma, -0.82 mm; lateral, -0.27 mm; and 413 ventral, 1.75 mm. 414 For injection, a cranial window was created on the skull to expose the brain area 415 targeted for tracing neurons. The virus was injected into the brain using a custom-established 416 injector fixed with a pulled glass pipette. The animal was placed in a warm cage after 417 injection for waking up and then transferred into a regular animal room. The animals were 418 kept for 7 d after RV and 28 d after AAV injection before perfusion. j) The high-magnification images of cleared brains reveal fine structures at different positions of the brain, 595 including the midbrain (e), hippocampus (f), cerebellum (g), striatum (h), cortex (i), and cerebellar nuclei (j). 596 (k) 3D reconstruction of RV-labelled afferent projections to nucleus reuniens (RE) throughout the whole 597 brain. (l-q) Several regions of specific projections to RE, including the dorsal/ventral agranular insular cortex 598
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